Signaling pathways and targeted therapies in Ewing sarcoma-Reference-Cited by-同舟云学术

Signaling pathways and targeted therapies in Ewing sarcoma

Published:2025-02 Issue: Volume:266 Page:108765
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Jia Ke,Cao Li,Yu Yihan,Jing Doudou,Wu Wei,Van Tine Brian Andrew,Shao Zengwu

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference680 articles.

1. Prognostic implications of PD-l1 expression and loss of pten in patients with rhabdomyosarcoma, Ewing’s sarcoma and osteosarcoma;Abd Elmoneim;Experimental Oncology,2023

2. The EPH/Ephrin System in Bone and Soft Tissue Sarcomas’ Pathogenesis and Therapy: New Advancements and a Literature Review;Ac;International Journal of Molecular Sciences,2022

3. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma;Adane;Cancer Cell,2021

4. PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview;Adibi;Therapeutic Advances in Medical Oncology,2023

5. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma;Agelopoulos;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined inhibition of ribonucleotide reductase and WEE1 induces synergistic anticancer activity in Ewing’s sarcoma cells;BMC Cancer;2025-02-17

2. Primary Retroperitoneal Extraskeletal Ewing’s Sarcoma: A Case Report;Advances in Clinical Medicine;2025